Thermo Fisher to Buy Olink in $3.1 Billion Deal
By Colin Kellaher
Life-sciences giant Thermo Fisher Scientific has struck a $3.1 billion deal to buy Swedish proteomics company Olink Holding.
Thermo Fisher on Tuesday said it will pay $26 a share in cash for Olink, a nearly 74% premium to Monday's closing price of $14.98.
Thermo Fisher said the acquisition of Olink, which offers solutions for advanced proteomics discovery and development, is highly complementary to its mass-spectrometry and life-sciences platforms.
Thermo Fisher, based in Waltham, Mass., plans to fund the acquisition with cash on hand and debt financing, adding that the deal is slated to close by mid-2024.
Trading in shares of Olink was halted premarket on Tuesday.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
October 17, 2023 08:46 ET (12:46 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening In the Markets This Week
-
Can the Fed Declare Victory on Inflation?
-
After Earnings and a 56% Rally In 2024, Is Arm Stock a Buy, a Sell, or Fairly Valued?
-
How Morningstar Rates Stocks
-
After Earnings, Is Disney Stock a Buy, a Sell, or Fairly Valued?
-
Home Depot Earnings: Macro Factors Pinch Demand, but Long-Term Outlook Intact
-
Tariffs On Chinese EVs Offer US Automakers a Chance to Capture Demand
-
The Best REITs to Buy
-
3 Hot Stocks to Buy That Still Look Undervalued
-
After Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?